Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMC 1295586)

Published in BMC Infect Dis on October 27, 2005

Authors

Christian Østergaard1, Helle Bossen Konradsen, Susanne Samuelsson

Author Affiliations

1: National Center for Antimicrobials and Infection Control, Statens Serum Institut, Artillerivej 5, Copenhagen S, Denmark. coa@ssi.dk

Articles citing this

Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev (2010) 3.58

Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev (2011) 1.87

The burden of pneumococcal meningitis in Austrian children between 2001 and 2008. Eur J Pediatr (2014) 1.41

Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun (2010) 1.14

Clinical features, acute complications, and outcome of Salmonella meningitis in children under one year of age in Taiwan. BMC Infect Dis (2011) 1.09

Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev (2014) 1.03

Prognostic factors related to sequelae in childhood bacterial meningitis: data from a Greek meningitis registry. BMC Infect Dis (2011) 0.95

Influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis. BMC Infect Dis (2006) 0.93

Bacteremia causes hippocampal apoptosis in experimental pneumococcal meningitis. BMC Infect Dis (2010) 0.89

Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics (2013) 0.87

High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in CSF of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis. Antimicrob Agents Chemother (2009) 0.86

Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases. BMC Infect Dis (2006) 0.86

Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis Registry. PLoS One (2009) 0.83

Streptococcus pneumoniae Serotypes and Mortality in Adults and Adolescents in South Africa: Analysis of National Surveillance Data, 2003 - 2008. PLoS One (2015) 0.83

Tracking the transcriptional host response from the acute to the regenerative phase of experimental pneumococcal meningitis. BMC Infect Dis (2010) 0.80

Patterns of Local and Systemic Cytokines in Bacterial Meningitis and its Relation with Severity and Long-Term Sequelae. Biomark Insights (2015) 0.78

Clinical Prognosis in Neonatal Bacterial Meningitis: The Role of Cerebrospinal Fluid Protein. PLoS One (2015) 0.77

Streptococcus pneumoniae meningitis in Alberta pre- and postintroduction of the 7-valent pneumococcal conjugate vaccine. Can J Infect Dis Med Microbiol (2011) 0.75

Increase in hippocampal water diffusion and volume during experimental pneumococcal meningitis is aggravated by bacteremia. BMC Infect Dis (2014) 0.75

Adjunctive dexamethasone therapy in unconfirmed bacterial meningitis in resource limited settings: is it a risk worth taking? BMC Neurol (2016) 0.75

Early symptomatic and late seizures in Kosovar children with bacterial meningitis. Childs Nerv Syst (2011) 0.75

Articles cited by this

Dexamethasone in adults with bacterial meningitis. N Engl J Med (2002) 11.10

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet (2005) 7.99

Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med (2004) 7.87

Practice guidelines for the management of bacterial meningitis. Clin Infect Dis (2004) 7.79

Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA (2001) 4.90

Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis (2004) 3.43

Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain (2003) 3.19

Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med (1998) 2.91

Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis (2002) 2.05

Bacterial meningitis--a view of the past 90 years. N Engl J Med (2004) 1.77

Community-acquired bacterial meningitis in adults: categorization of causes and timing of death. Clin Infect Dis (2001) 1.74

Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev (2003) 1.68

A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child (2005) 1.59

Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol (2002) 1.36

Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases. Am J Respir Crit Care Med (2002) 1.32

Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study. Pediatr Infect Dis J (2002) 1.26

Dexamethasone and pneumococcal meningitis. Ann Intern Med (2004) 1.23

Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation. Arch Dis Child (2004) 1.14

Mortality in pneumococcal meningitis: a multivariate analysis of prognostic factors. Eur J Med (1993) 1.04

Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis (1995) 1.03

Differences in survival, brain damage, and cerebrospinal fluid cytokine kinetics due to meningitis caused by 3 different Streptococcus pneumoniae serotypes: evaluation in humans and in 2 experimental models. J Infect Dis (2004) 1.02

Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis (2000) 0.98

Pneumococcal meningitis: an evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae. J Infect (1985) 0.92

A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J Infect (1994) 0.91

Prognostic factors in pneumococcal meningitis. Arch Intern Med (1967) 0.88

Pneumococcal meningitis at Harlem hospital. N Y State J Med (1971) 0.87

Pneumococcal meningitis in adults. Scand J Infect Dis (1994) 0.86

Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria. J Antimicrob Chemother (2004) 0.86

[Dexamethasone to adults with acute bacterial meningitis]. Ugeskr Laeger (2003) 0.82

Clinical evaluation of pneumococcal meningitis in adults over a twelve-year period. Eur J Clin Microbiol Infect Dis (1989) 0.80

Articles by these authors

Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med (2003) 2.81

Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis (2004) 1.52

Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol (2005) 1.50

An easy method for detection of nasopharyngeal carriage of multiple Streptococcus pneumoniae serotypes. J Microbiol Methods (2008) 1.49

[Streptococcus pneumoniae meningitis in adults. Hvidovre University Hospital, 1988-2002]. Ugeskr Laeger (2005) 1.41

Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays. Vaccine (2007) 1.21

Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: systematic review. BMJ (2006) 1.09

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. Vaccine (2003) 1.08

Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. BMJ (2004) 1.08

Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics. Scand J Infect Dis (2006) 1.08

Differences in survival, brain damage, and cerebrospinal fluid cytokine kinetics due to meningitis caused by 3 different Streptococcus pneumoniae serotypes: evaluation in humans and in 2 experimental models. J Infect Dis (2004) 1.02

A 20-year ecological study of the temporal association between influenza and meningococcal disease. Eur J Epidemiol (2004) 1.00

Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J Clin Microbiol (2004) 1.00

Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study. J Clin Microbiol (2005) 0.93

Response to pneumococcal vaccine in chronic obstructive lung disease--the effect of ongoing, systemic steroid treatment. Vaccine (2005) 0.90

Serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccines. PLoS One (2013) 0.86

Nasopharyngeal pathogens in children with acute otitis media in a low-antibiotic use country. Int J Pediatr Otorhinolaryngol (2004) 0.76

Prehospital diagnostic and therapeutic management of otogenic Streptococcus pneumoniae meningitis. Scand J Infect Dis (2006) 0.75

Impact of positive chest X-ray findings and blood cultures on adverse outcomes following hospitalized pneumococcal lower respiratory tract infection: a population-based cohort study. BMC Infect Dis (2013) 0.75

[Severe acute respiratory syndrome--SARS]. Ugeskr Laeger (2003) 0.75

[Surveillance and prevention of nosocomial Legionella pneumonia]. Ugeskr Laeger (2002) 0.75